These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20694122)

  • 1. An open-label trial of topiramate in the treatment of skin picking in pervasive developmental disorder not otherwise specified.
    Jafferany M; Shireen F; Ibrahim A
    Prim Care Companion J Clin Psychiatry; 2010; 12(2):. PubMed ID: 20694122
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders.
    Hardan AY; Jou RJ; Handen BL
    J Child Adolesc Psychopharmacol; 2004; 14(3):426-32. PubMed ID: 15650499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy in patients with pervasive developmental disorder not otherwise specified.
    Parmeggiani A; Posar A; Antolini C; Scaduto MC; Santucci M; Giovanardi-Rossi P
    J Child Neurol; 2007 Oct; 22(10):1198-203. PubMed ID: 17940246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-autistic pervasive developmental disorders: Rett syndrome, disintegrative disorder and pervasive developmental disorder not otherwise specified].
    Mercadante MT; Van der Gaag RJ; Schwartzman JS
    Braz J Psychiatry; 2006 May; 28 Suppl 1():S12-20. PubMed ID: 16791387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.
    Shapira NA; Lessig MC; Murphy TK; Driscoll DJ; Goodman WK
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):141-5. PubMed ID: 12135538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left temporal arachnoid cyst and specific learning disorders associated with Pervasive Developmental Disorders - Not Otherwise Specified (PDD-NOS): contributions of an integrative neuropsychomotor, neuropsychological, psychopathological and neurosurgical approach about a case report in a child (François)].
    Vaivre-Douret L; Boschi A; Cuny ML; Clouard C; Mosser A; Golse B; Philippe A; Bourgeois M; Boddaert N; Puget S
    Encephale; 2016 Dec; 42(6):582-588. PubMed ID: 27644917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
    McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
    J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
    McDougle CJ; Holmes JP; Bronson MR; Anderson GM; Volkmar FR; Price LH; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label study of olanzapine in children with pervasive developmental disorder.
    Kemner C; Willemsen-Swinkels SH; de Jonge M; Tuynman-Qua H; van Engeland H
    J Clin Psychopharmacol; 2002 Oct; 22(5):455-60. PubMed ID: 12352267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of intensive early intervention for children with pervasive developmental disorder.
    Smith T; Groen AD; Wynn JW
    Am J Ment Retard; 2000 Jul; 105(4):269-85. PubMed ID: 10934569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of developmental/intellectual changes between autistic disorder and pervasive developmental disorder not otherwise specified in preschool years.
    Takeda T; Koyama T; Kurita H
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):684-6. PubMed ID: 18081633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine treatment of pathologic skin picking: an open-label study.
    Grant JE; Odlaug BL; Kim SW
    J Clin Psychiatry; 2007 Sep; 68(9):1384-91. PubMed ID: 17915977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual obsessions, compulsions, suicidality and homicidality in an adolescent diagnosed with bipolar disorder not otherwise specified, obsessive-compulsive disorder, pervasive developmental disorder not otherwise specified, and mild mental retardation.
    Singh G; Coffey BJ
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):250-3. PubMed ID: 22612525
    [No Abstract]   [Full Text] [Related]  

  • 14. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
    Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in Excoriation (Skin-Picking) with use of Risperidone in a Patient with Developmental Disability.
    Roi C; Bazzano A
    Pediatr Rep; 2017 Mar; 9(1):6946. PubMed ID: 28435649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
    Andrus MR; Gilbert E
    Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive behavior in autism and Pervasive Developmental Disorder-Not Otherwise Specified: microanalysis of scores on the Vineland Adaptive Behavior Scales.
    Paul R; Miles S; Cicchetti D; Sparrow S; Klin A; Volkmar F; Coflin M; Booker S
    J Autism Dev Disord; 2004 Apr; 34(2):223-8. PubMed ID: 15162940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Skills Groups for Asperger's Disorder and Pervasive Developmental Disorder Not Otherwise Specified.
    Countryman J
    Psychiatry (Edgmont); 2008 Jan; 5(1):42-7. PubMed ID: 19727303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
    Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ
    J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.